Table 1.
Characteristics of participants.
| Variables | Total (n = 15388) | Survivors (n = 13055) | Non-survivors (n =2333) | P-value |
|---|---|---|---|---|
| Age group, n (%) | 15388 | 13055 | 2333 | <0.001 |
| 60 | 10856 (70.55) | 10137 (77.65) | 719 (30.82) | |
| ≥ 60 | 4532 (29.45) | 2918 (22.35) | 1614 (69.18) | |
| Sex, n (%) | <0.001 | |||
| Female | 8076 (52.48) | 6638 (50.85) | 1438 (61.64) | |
| Male | 7312 (47.52) | 6417 (49.15) | 895 (38.36) | |
| PIR, n (%) | <0.001 | |||
| 1 | 1303 (8.47) | 980 (7.51) | 323 (13.84) | |
| 1–3 | 4593 (29.85) | 3997 (30.62) | 596 (25.55) | |
| 3 | 9492 (61.68) | 8078 (61.88) | 1414 (60.61) | |
| Race, n (%) | <0.001 | |||
| Non-Hispanic Black | 1971 (12.81) | 1475 (11.30) | 496 (21.26) | |
| Mexican American | 1514 (9.84) | 854 (6.54) | 660 (28.29) | |
| Non-Hispanic White | 11084 (72.03) | 10464 (80.15) | 620 (26.58) | |
| Other Race | 819 (5.32) | 262 (2.01) | 557 (23.87) | |
| Education levels, n (%) | <0.001 | |||
| high school | 1976 (12.84) | 675 (5.17) | 1301 (55.77) | |
| = high school | 5038 (32.74) | 4418 (33.84) | 620 (26.58) | |
| high school | 8374 (54.42) | 7962 (60.99) | 412 (17.66) | |
| Smoking status, n (%) | <0.001 | |||
| Never | 7752 (50.38) | 6941 (53.17) | 811 (34.76) | |
| Former | 3674 (23.88) | 2979 (22.82) | 695 (29.79) | |
| Current | 3962 (25.75) | 3135 (24.01) | 827 (35.45) | |
| Alcoholconsumption, n (%) | <0.001 | |||
| Never | 1733 (11.26) | 1482 (11.35) | 251 (10.76) | |
| Former | 2285 (14.85) | 1222 (9.36) | 1063 (45.56) | |
| Mild | 6207 (39.17) | 5376 (41.18) | 831 (35.62) | |
| Moderate | 2341 (15.21) | 2249 (17.23) | 92 (3.94) | |
| Heavy | 3002 (19.51) | 2726 (20.88) | 276 (11.83) | |
| Diabetes, n (%) | <0.001 | |||
| No | 10809 (70.24) | 9380 (71.85) | 1429 (61.25) | |
| IFG | 1328 (8.63) | 1074 (8.23) | 254 (10.89) | |
| IGT | 1470 (9.55) | 1116 (8.55) | 354 (15.17) | |
| Yes | 1781 (11.57) | 1485 (11.37) | 296 (12.69) | |
| Hyperlipidemia, n (%) | <0.001 | |||
| No | 9364 (60.85) | 9089 (69.16) | 275 (11.79) | |
| Yes | 6024 (39.15) | 3966 (30.84) | 2058 (88.21) | |
| Hypertension, n (%) | <0.001 | |||
| No | 13640 (88.64) | 11452 (87.72) | 2188 (93.78) | |
| Yes | 1748 (11.36) | 1603 (13.28) | 145 (6.22) | |
| Cancer, n (%) | <0.001 | |||
| No | 4850 (31.52) | 2798 (16.43) | 2052 (87.96) | |
| Yes | 10538 (68.48) | 10257 (78.57) | 281 (12.05) | |
| Lipiddrug, n (%) | <0.001 | |||
| No | 12521 (81.37) | 10512 (80.52) | 2009 (86.11) | |
| Yes | 2867 (18.63) | 2543 (19.48) | 324 (13.89) | |
| Laboratory data | ||||
| FBG (mmol/L) | 5.40 (5.07,5.85) | 5.30 (5.05,5.70) | 5.87 (5.44,6.37) | <0.001 |
| TG (mmol/L) | 1.10 (0.85,1.70) | 1.08 (0.84,1.63) | 1.35 (1.03,1.87) | <0.001 |
| LDL-C (mmol/L) | 2.85 (2.30,3.45) | 2.80 (2.34,3.36) | 2.90 (2.35,3.67) | <0.001 |
| ALT (U/L) | 20.00 (15.00,27.00) | 19.00 (16.00,25.00) | 21.00 (17.00,25.00) | <0.001 |
| AST (U/L) | 22.00 (18.00,27.00) | 22.00 (19.00,27.00) | 23.00 (20.00,27.00) | <0.001 |
| WBC (109/L) | 6.20 (5.10,7.60) | 6.00 (5.20,7.60) | 6.70 (5.50,8.00) | <0.001 |
| PLT (109/L) | 240.00 (200.00,285.00) | 235.00 (200.00,268.00) | 250.00 (210.00,280.00) | <0.001 |
| Neutrophils (109/L) | 3.40 (2.70,4.40) | 3.30 (2.60,4.40) | 4.00 (3.00,4.90) | <0.001 |
| Monocytes (109/L) | 0.50 (0.40,0.60) | 0.50 (0.40,0.60) | 0.60 (0.40,0.70) | <0.001 |
| Lymphocytes (109/L) | 1.80 (1.50,2.20) | 1.90 (1.60,2.30) | 1.70 (1.30,2.20) | <0.001 |
| Follow-up time (month) | 118 (85,182) | 127 (75,173) | 106 (65,156) | <0.001 |
BMI, body mass index; PIR, poverty income ratio; IFG,impaired fasting glucose; IGT, impaired glucose tolerance; FBG, fasting blood glucose; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; ALT, alanine aminotransferase; AST, aspartate aminotransferase; WBC, white blood cell; PLT, platelet; TyG, triglyceride-glucose; NLR, neutrophil-lymphocyte ratio.